| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 11 4743-4753, Copyright © 1993 by American Association of Immunologists
ARTICLES |
M Daeipour, G Kumar, MC Amaral and AE Nel
Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90024.
IL-6 is a multi-functional cytokine that utilizes 80-kDa ligand-binding and 130-kDa signal-transducing subunits to stimulate diverse cellular responses. Although IL-6R ligation has been associated with tyrosine protein phosphorylation and activation of an unidentified serine/threonine kinase, very little is known about the intermediary signaling events between the cell membrane and the nucleus. rIL-6 treatment of the human B cell line, AF-10, induced MAP kinase (mitogen- activated protein kinase) activity as determined by in vitro phosphorylation of microtubule-associated protein-2 (MAP-2) and the synthetic peptide APRTPGGRR, corresponding to amino acids 95-98 of bovine myelin basic protein. The kinetics of the response was rapid and dependent on the dose of rIL-6. The response was cytokine specific, did not require the presence of extracellular Ca2+, and was minimally affected by the presence of staurosporine. MAP kinase activation in AF- 10 cells occurred in parallel with appearance of 42- and 44-kDa tyrosine phosphoproteins (p42 and p44). Moreover, MAP kinase activation was diminished when AF-10 cells were stimulated with rIL-6 in the presence of tyrosine protein kinase inhibitors, genistein and geldanomycin. p42 and p44 co-electrophoresed on SDS-PAGE with extracellular signal-related kinase (ERK)-2, and ERK-1, respectively; both are members of the ERK family. In addition to p42MAPK and p44MAPK, rIL-6 also activated a MAP-2 kinase that eluted at a lower salt concentration (20 to 60 mM NaCl, peak I) from Mono-Q resin than p42MAPK (120 to 180 mM NaCl, peak II). The identify of this kinase is unknown but it is not an MPB kinase or a protein that exhibits immunoreactivity with anti-ERK antisera. In another IL-6-responsive B cell line, SKW6.4, rIL-6-activated peak I MAP-2 kinase but failed to activate ERK-2. The protein kinase C agonist, PMA, did, however, activate ERK-2 in SKW6.4 cells. These results show that the pleiotrophic cytokine, IL-6, activates p42MAPK/ERK-2 and at least one other serine/threonine kinase in B cell lines.
This article has been cited by other articles:
|
|
 |
|
  M. B. Nilsson, R. R. Langley, and I. J. Fidler Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine Cancer Res., December 1, 2005; 65(23): 10794 - 10800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fricke, A. Heitland, and E. Maronde Cooperative Activation of Lipolysis by Protein Kinase A and Protein Kinase C Pathways in 3T3-L1 Adipocytes Endocrinology, November 1, 2004; 145(11): 4940 - 4947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Cui, F. N. Rouhani, F. Hawari, and S. J. Levine An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding J. Biol. Chem., August 1, 2003; 278(31): 28677 - 28685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Leng, C. N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R. A. Mitchell, and R. Bucala MIF Signal Transduction Initiated by Binding to CD74 J. Exp. Med., June 2, 2003; 197(11): 1467 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shi, J. Gera, J.-h. Hsu, B. Van Ness, and A. Lichtenstein Cytoreductive Effects of Farnesyl Transferase Inhibitors on Multiple Myeloma Tumor Cells Mol. Cancer Ther., June 1, 2003; 2(6): 563 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hu, Y. Shi, J.-h. Hsu, J. Gera, B. Van Ness, and A. Lichtenstein Downstream effectors of oncogenic ras in multiple myeloma cells Blood, April 15, 2003; 101(8): 3126 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Legendre, J. Dudhia, J.-P. Pujol, and P. Bogdanowicz JAK/STAT but Not ERK1/ERK2 Pathway Mediates Interleukin (IL)-6/Soluble IL-6R Down-regulation of Type II Collagen, Aggrecan Core, and Link Protein Transcription in Articular Chondrocytes. ASSOCIATION WITH A DOWN-REGULATION OF SOX9 EXPRESSION J. Biol. Chem., January 24, 2003; 278(5): 2903 - 2912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Diehl, C.-W. Chow, L. Weiss, A. Palmetshofer, T. Twardzik, L. Rounds, E. Serfling, R. J. Davis, J. Anguita, and M. Rincon Induction of NFATc2 Expression by Interleukin 6 Promotes T Helper Type 2 Differentiation J. Exp. Med., July 1, 2002; 196(1): 39 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, J.-h. Hsu, L. Hu, J. Gera, and A. Lichtenstein Signal Pathways Involved in Activation of p70S6K and Phosphorylation of 4E-BP1 following Exposure of Multiple Myeloma Tumor Cells to Interleukin-6 J. Biol. Chem., May 3, 2002; 277(18): 15712 - 15720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Conze, L. Weiss, P. S. Regen, A. Bhushan, D. Weaver, P. Johnson, and M. Rincon Autocrine Production of Interleukin 6 Causes Multidrug Resistance in Breast Cancer Cells Cancer Res., December 1, 2001; 61(24): 8851 - 8858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Smola-Hess, U. Sandaradura de Silva, D. Hadaschik, and H. J. Pfister Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner J. Gen. Virol., October 1, 2001; 82(10): 2335 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tu, A. Gardner, and A. Lichtenstein The Phosphatidylinositol 3-Kinase/AKT Kinase Pathway in Multiple Myeloma Plasma Cells: Roles in Cytokine-dependent Survival and Proliferative Responses Cancer Res., December 1, 2000; 60(23): 6763 - 6770. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Renner, J. Weisz, S. Krajewski, M. Krajewska, J. C. Reed, and A. Lichtenstein Expression of BAX in Plasma Cell Dyscrasias Clin. Cancer Res., June 1, 2000; 6(6): 2371 - 2380. [Abstract] [Full Text]
|
|
|
|
|
|
F. C. von Lintig, I. Huvar, P. Law, M. B. Diccianni, A. L. Yu, and G. R. Boss Ras Activation in Normal White Blood Cells and Childhood Acute Lymphoblastic Leukemia Clin. Cancer Res., May 1, 2000; 6(5): 1804 - 1810. [Abstract] [Full Text]
|
|
|
|
|
|
T. Hideshima, D. Chauhan, G. Teoh, N. Raje, S. P. Treon, Y.-T. Tai, Y. Shima, and K. C. Anderson Characterization of Signaling Cascades Triggered by Human Interleukin-6 versus Kaposi's Sarcoma-associated Herpes Virus-encoded Viral Interleukin 6 Clin. Cancer Res., March 1, 2000; 6(3): 1180 - 1189. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. BOKEMEYER, T. OSTENDORF, U. KUNTER, M. LINDEMANN, H. J. KRAMER, and J. FLOEGE Differential Activation of Mitogen-Activated Protein Kinases in Experimental Mesangioproliferative Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2000; 11(2): 232 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Wu and R. A. Bradshaw Activation of the Stat3 Signaling Pathway Is Required for Differentiation by Interleukin-6 in PC12-E2 Cells J. Biol. Chem., January 21, 2000; 275(3): 2147 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rivest, S. Lacroix, L. Vallières, S. Nadeau, J. Zhang, and N. Laflamme How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli Experimental Biology and Medicine, January 1, 2000; 223(1): 22 - 38. [Abstract] [Full Text]
|
|
|
|
|
|
X. Yang, Y. Chen, and D. Gabuzda ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-kappa B J. Biol. Chem., September 24, 1999; 274(39): 27981 - 27988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-h. Xu, S. Sharma, A. Gardner, Y. Tu, A. Raitano, C. Sawyers, and A. Lichtenstein Interleukin-6-Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway Blood, July 1, 1998; 92(1): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Kinugawa, T. Shimizu, A. Yao, O. Kohmoto, T. Serizawa, and T. Takahashi Transcriptional Regulation of Inducible Nitric Oxide Synthase in Cultured Neonatal Rat Cardiac Myocytes Circ. Res., December 19, 1997; 81(6): 911 - 921. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.-P. Sung, A. J. Arleth, C. Eichman, A. Truneh, and E. H. Ohlstein Carvedilol, a Multiple-Action Neurohumoral Antagonist, Inhibits Mitogen-Activated Protein Kinase and Cell Cycle Progression in Vascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 910 - 917. [Abstract] [Full Text]
|
|
|
|
|
|
D. Chauhan, S. Kharbanda, A. Ogata, M. Urashima, G. Teoh, M. Robertson, D. W. Kufe, and K. C. Anderson Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells Blood, January 1, 1997; 89(1): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Berger and R. G. Hawley Interferon-beta Interrupts Interleukin-6-Dependent Signaling Events in Myeloma Cells Blood, January 1, 1997; 89(1): 261 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Kulas, G. G. Freund, and R. A. Mooney The Transmembrane Protein-tyrosine Phosphatase CD45 Is Associated with Decreased Insulin Receptor Signaling J. Biol. Chem., January 12, 1996; 271(2): 755 - 760. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
